Jasdeep Manik
Optometrist · Stanford, CANPI 1912324112
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $820 and has fallen 86.3% since, to $112 in 2025.
Across 99 payments — averaging $24.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$483
- Bausch & Lomb, A Division Of Bausch Health US, LLC$258
- Biotissue Holdings Inc.$233
- Oyster Point Pharma, Inc.$221
- AbbVie$192
- Bausch & Lomb Americas Inc.$164
- plus $833 from 11 others
What the payments were for
- Food & beverage$2,36599%
- Gifts$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 19 | $483 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 14 | $258 |
| Biotissue Holdings Inc. | 8 | $233 |
| Oyster Point Pharma, Inc. | 12 | $221 |
| AbbVie(2 entities) | 5 | $192 |
| Bausch & Lomb Americas Inc. | 7 | $164 |
| Novartis | 7 | $147 |
| Dompe US, Inc. | 3 | $125 |
| Aerie Pharmaceuticals, Inc. | 1 | $111 |
| Shire North American Group Inc | 5 | $108 |
| Sight Sciences, Inc. | 6 | $104 |
| Kala Pharmaceuticals, Inc. | 5 | $87 |
| Alcon | 2 | $47 |
| ANI Pharmaceuticals, Inc. | 2 | $44 |
| Harrow Eye, LLC | 1 | $21 |
| Eyevance Pharmaceuticals LLC | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,384 in reported general payments places this provider in the 80th percentile of 6,778 optometrist providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 18 | $20,774 |
| LumiganBimatoprost | 11 | $7,028 |
| RocklatanNetarsudil Mesylat/Latanoprost | 12 | $5,418 |
| Cyclosporine | 12 | $2,746 |
| Latanoprost | 58 | $472 |
| Timolol Maleate | 19 | $356 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan | $192 | $27,80229 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan | $111 | $5,41812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,778 optometrist providers in California.
Other optometrist in Stanford
- Susan SuStanford$147K
- Steve YoelinNewport Beach$4.1M
- Matthew GellerSpring Valley$3.5M
- Melissa EricksonDavis$522K
- Omid KhodaiLake Forest$499K
- Jason TuSan Diego$351K
- Scott SchachterPismo Beach$312K
- Alicia LauSan Diego$300K
- Vin DangBakersfield$284K
- Steven FerrucciSepulveda$272K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.